7:33 PM
 | 
Mar 02, 2005
 |  BC Extra  |  Company News

First Horizon acquires two Andrx drugs

FHRX will acquire U.S. rights to Fortamet extended-release metformin and Altoprev extended-release lovastatin from ADRX for $50 million up front. Fortamet, which was launched in May 2004...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >